Prevention and control of influenza. Recommendations of the Immunization Practices Advisory Committee (ACIP)
D000368:Aged; D000547:Amantadine / Q000009:adverse effects / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D002487:Centers for Disease Control and Prevention, U.S.; D002648:Child; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D009980:Influenza A virus / Q000187:drug effects; D009981:Influenza B virus; D007252:Influenza Vaccines / Q000009:adverse effects; D007251:Influenza, Human / Q000188:drug therapy / Q000517:prevention & control*; D011247:Pregnancy; D014481:United States; D014611:Vaccination
D000998:Antiviral Agents; D007252:Influenza Vaccines; D000547:Amantadine